Objectives We examined major issues associated with sharing of individual clinical trial data
and developed a consensus document on providing access to individual participant data …

Objectives To explore the impact of data-sharing initiatives on the intent to share data, on
actual data sharing, on the use of shared data and on research output and impact of shared …

Background Individual participant data (IPD) from completed clinical trials should be
responsibly shared to support efficient clinical research, generate new knowledge and bring …

Background The move towards increased transparency around clinical trials is welcome.
Much focus has been on under-reporting of trials and access to individual patient data to …

Background Health-related research funders, regulators and journals expect that de-
identified individual-level health data be shared widely, with as few restrictions as possible; …

Representatives of the Wellcome Trust, the Medical Research Council, Cancer Research
UK, and the Bill and Melinda Gates Foundation describe the importance of sharing clinical …

Objective To investigate clinical trialists' opinions and experiences of sharing of clinical trial
data with investigators who are not directly collaborating with the research team. Design and …

Background Data repositories have the potential to play an important role in the effective
and safe sharing of individual-participant data (IPD) from clinical studies. We analysed the …

International calls for registering all trials involving humans and for sharing the results, and
sometimes also the raw data and the trial protocols, have increased in recent years. Such …

Background Sharing of raw research data is common in many areas of medical research,
genomics being perhaps the most well-known example. In the clinical trial community …